Cargando…
Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia
OBJECTIVE: The aim of the study was to assess the role of mid-regional proadrenomedullin (MR-proADM) in comparison with routine laboratory tests in patients with COVID-19. MATERIALS AND METHODS: 140 hospitalized patients aged 18 and older with COVID-19 pneumonia were included in prospective single-c...
Autores principales: | Astapovskii, Aleksandr A., Drozdov, Vladimir N., Shikh, Evgenia V., Melkonyan, George G., Sizova, Zhanna M., Zakharova, Valeria L., Shindryaeva, Natalia N., Lapidus, Natalia I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441885/ https://www.ncbi.nlm.nih.gov/pubmed/36072940 http://dx.doi.org/10.3389/fmed.2022.961071 |
Ejemplares similares
-
Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis
por: Fahmey, Sameh Samir, et al.
Publicado: (2018) -
Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia
por: Suberviola, B, et al.
Publicado: (2011) -
Acute exacerbations of copd (AECOPD) in the emergency room (ER): prognostic value of proadrenomedulline (PROADM)
por: Dres, M, et al.
Publicado: (2015) -
Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients
por: Indirli, Rita, et al.
Publicado: (2022) -
Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy study
por: Alcoba, Gabriel, et al.
Publicado: (2015)